Drug Trial Radar · NCT04078295
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
125
Actual
Start
Sep 5, 2019
Primary completion
Mar 31, 2027
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Eisai Co., Ltd.Eisai
- Sponsor type
- Industry
- Collaborators
- Ono Pharmaceutical Co., Ltd.
- First posted
- Sep 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate safety and tolerability of E7389 liposomal formulation (E7389-LF) in combination with nivolumab and to determine the recommended Phase 2 dose (RP2D) in Phase 1b part and to evaluate objective response rate (ORR) of E7389-LF and nivolumab using RP2D in each tumor type in Phase 2 part.
Conditions
- Solid Neoplasms
Interventions
E7389-LFDrug
E7389-LF Intravenous infusion.
NivolumabDrug
Nivolumab Intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1b: Number of Participants with Dose Limiting Toxicities (DLTs)Time frame: Baseline up to Cycle 1 (Cycle length is equal to [=] up to 28 days)
- Phase 2: ORRTime frame: Baseline up to End of Treatment (Up to approximately 79 months)
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Eisai Trial Site #12
Kōtoku, Japan
Eisai Trial Site #13
Nagoya, Aichi-ken, Japan
Eisai Trial Site #18
Kashiwa, Chiba, Japan
Eisai Trial Site #2
Kashiwa, Chiba, Japan
Eisai Trial Site #14
Matsuya, Ehime, Japan
Eisai Trial Site #4
Kurume, Fukuoka, Japan
Eisai Trial Site #11
Akashi, Hyōgo, Japan
Eisai Trial Site #15
Yokohama, Kanaga, Japan
Eisai Trial Site #3
Sendai, Miyagi, Japan
Eisai Trial Site #6
Chuo Ku, Osaka, Japan
Eisai Trial Site #8
Chuo Ku, Osaka, Japan
Eisai Trial Site #5
Osakasa, Osaka, Japan
Eisai Trial Site #7
Sakai C, Osaka, Japan
Eisai Trial Site #17
Suita, Osaka, Japan
Eisai Trial Site #19
Kitaadachi-gun, Saitama, Japan
Eisai Trail Site #16
Sunto-g, Shizuo, Japan
Eisai Trial Site #1
Chuo Ku, Tokyo, Japan
Eisai Trial Site #10
Koto-Ku, Tokyo, Japan
Eisai Trial Site #9
Wakayama, Wakaya, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.